Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location Prognostic p-value RNA cancer category RNA tissue category RNA TS RNA TS TPM TPM max in non-specific CYB561 CYB561A1, FRRS2 ENSG00000008283 Cytochrome b561 17 63432304-63446378 Predicted membrane proteins, Transporters Evidence at protein level HPA014753 Approved Endometrial cancer:2.95e-5 (favourable), Breast cancer:8.89e-5 (unfavourable) Expressed in all Expressed in all adrenal gland: 164.3 CYBA p22-PHOX ENSG00000051523 Cytochrome b-245, alpha polypeptide 16 88643283-88651152 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level CAB009492 Supported Endometrial cancer:4.75e-5 (favourable), Renal cancer:1.83e-4 (unfavourable), Breast cancer:8.19e-4 (favourable) Expressed in all Expressed in all spleen: 476.3 CYBB CGD, GP91-PHOX, NOX2 ENSG00000165168 Cytochrome b-245, beta polypeptide X 37780011-37813461 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level HPA051227 Supported Expressed in all Tissue enhanced appendix: 221.1 lung: 132.4 DUOX1 LNOX1, NOXEF1, THOX1 ENSG00000137857 Dual oxidase 1 15 45129933-45165576 Enzymes, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level HPA023544 Approved Cervical cancer:4.31e-6 (favourable) Tissue enhanced Tissue enhanced skin: 96.8;thyroid gland: 92.3 esophagus: 73.4 DUOX2 LNOX2, P138(TOX), P138-TOX, THOX2 ENSG00000140279 Dual oxidase 2 15 45092650-45114344 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Tissue enhanced Group enriched 6 gallbladder: 448.6;thyroid gland: 124.3;urinary bladder: 90.1 stomach: 38.5 KCNIP4 CALP, KCHIP4, MGC44947 ENSG00000185774 Kv channel interacting protein 4 4 20728616-21948799 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA022862, HPA066717 Supported Approved Vesicles Mixed Tissue enhanced cerebral cortex: 57.4 cervix, uterine: 20.5 NOX1 GP91-2, MOX1, NOH-1, NOH1 ENSG00000007952 NADPH oxidase 1 X 100843324-100874345 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Colorectal cancer:9.71e-4 (favourable) Tissue enriched Group enriched 17 colon: 60.0;rectum: 81.1 appendix: 4.0 NOX3 GP91-3 ENSG00000074771 NADPH oxidase 3 6 155395370-155455903 Predicted membrane proteins, Transporters Evidence at protein level HPA073837 Uncertain Vesicles Not detected Not detected adrenal gland: 0.1 NOX4 KOX, KOX-1 ENSG00000086991 NADPH oxidase 4 11 89324356-89498187 Predicted membrane proteins, Transporters Evidence at protein level HPA015475 Uncertain Approved Nucleus Renal cancer:6.14e-4 (favourable) Mixed Tissue enriched 12 kidney: 133.6 parathyroid gland: 10.7 NOX5 NOX5A, NOX5B ENSG00000255346 NADPH oxidase, EF-hand calcium binding domain 5 15 68930525-69062743 Predicted membrane proteins, Transporters Evidence at protein level Not detected Tissue enhanced spleen: 13.4 testis: 3.6 STEAP1 PRSS24, STEAP ENSG00000164647 Six transmembrane epithelial antigen of the prostate 1 7 90154375-90164829 Cancer-related genes, Predicted membrane proteins, Transporters Evidence at protein level HPA030985 Uncertain Tissue enriched Tissue enhanced prostate: 124.2 appendix: 41.5 STEAP2 IPCA-1, PCANAP1, STAMP1, STMP ENSG00000157214 STEAP family member 2, metalloreductase 7 90167590-90238137 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA029115, HPA055603 Uncertain Supported Vesicles Tissue enriched Tissue enriched 11 prostate: 205.1 parathyroid gland: 18.5 STEAP4 FLJ23153, STAMP2, TIARP, TNFAIP9 ENSG00000127954 STEAP family member 4 7 88270892-88306891 Predicted membrane proteins, Transporters Evidence at protein level HPA075871 Supported Golgi apparatus Liver cancer:2.97e-4 (favourable), Stomach cancer:5.77e-4 (unfavourable) Tissue enhanced Expressed in all adipose tissue: 129.9